Welcome to Prospect! We use the same data as VCs to help you find the best startups and understand what your equity is likely to be worth.
View more companies

Momentous

Momentous provides science-backed nutritional supplements, trusted by professional sports teams and independently tested for purity, quality, and performance.

Secondary Market Price

Updated: 
Feb 2026
Current Preferred Price
Date:
Sign in to view
Prospect Projected Preferred
Current FMV
Date:
Sign in to view
Prospect Projected FMV
$26M
Company Valuation
Updated: 
Feb 2026
Health
Industry
Park City, UT
Headquarters
2016
Year Founded
80+
Employee Count

How Momentous Measures Up

To help you manage your Momentous equity, Prospect has run the company through our machine learning model.

Prospect Rating

--

This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.

Exit Risk

--

Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.

Funding Stage

TBD

A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.

Est val $26M
--
Feb 6, 2026

Create a free account to unlock real-time secondary market prices and future projections of Momentous's value.

Sign up to Unlock the Latest Data
Failed to load data. Using sample data.
Loading chart…

Data will be available soon.
Sign up to receive notifications when it is available.

Sign up to get notified
Sign up to Unlock the Latest Data

Prospect Projected Future Momentous Prices

Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Momentous's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description

Momentous develops and sells human performance supplements, with a focus on science-backed formulations and third-party testing. The company's products, which include Creatine Chews, Whey Protein Isolate, and Berberine, are used by individual consumers, over 150 professional and NCAA sports teams, and the U.S. military. Historically, the company was established to bring more credibility to the supplement industry through transparent sourcing and expert collaboration. It has been awarded 11 innovation and research contracts from the U.S. Department of Defense to aid clinical research and product development for military personnel.

Recent company activity includes the release of new products, such as Berberine, and new flavors for its Creatine Chews. Momentous has also entered into a collaboration with Arnold Schwarzenegger and is promoting specific product protocols like "The Women’s Three," which was developed with Dr. Stacy Sims. While explicit future plans are not stated, the company's ongoing research contracts and partnerships with experts in performance science indicate a continued focus on expanding its product line and advancing clinical research.

Momentous Notable Investors

  • Humble Growth
  • DSM Venturing
  • FitLab

Momentous Founders

  • Co-Founder, Jeff Byers
  • Co-Founder, Tim Caron

Peer Group Comparison

Vs Peer Group of >$4B Startups

Frequently Asked Questions

Is Anduril worth joining?

Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.

Is Momentous worth joining?

Evaluating a startup offer involves many factors, especially the potential value of its equity compensation. Tools like Prospect can help you analyze the financial upside by providing data-driven projections on a company's future value.

What should I do with my Momentous stock?

Deciding what to do with your startup stock involves complex tax and financial planning that is unique to your personal situation. Platforms like Prospect can build a personalized strategy for you, helping you decide when to exercise options or sell shares to maximize your after-tax returns.

Can you sell Momentous stock?

As Momentous is a private company, you can typically only sell shares during specific events like a tender offer or on a secondary market. Prospect offers Tender Offer Tools to help you navigate these opportunities and determine which shares are the most tax-optimal to sell.

How can I find the value of my Momentous stock?

The value of private stock is typically determined by a 409A valuation, but this doesn't always reflect its potential future worth. To get a better forecast, you can use platforms like Prospect, which uses predictive models to project the future value of your shares.

What is Momentous's equity worth?

The exact worth of a private company's equity is unknown until a liquidity event like an IPO or acquisition occurs. However, tools like Prospect can provide data-driven projections to help you estimate the potential future value of your holdings.

What is Momentous's stock ticker symbol?

As a private company, Momentous does not have a stock ticker symbol because its shares are not traded on a public stock exchange. Ticker symbols are assigned only when a company undergoes an Initial Public Offering (IPO).

Can I buy or sell Momentous stock?

Buying stock is generally limited to exercising your employee stock options, while selling is possible during specific windows like tender offers or on secondary markets. Prospect provides option exercise strategies and other tools to help you make informed decisions on when to buy or sell your shares.

What is the criteria to buy or invest in Momentous stock?

For employees, the primary way to acquire stock is by exercising options granted to you as part of your compensation package. Investing as an outsider is typically restricted to accredited investors participating in the company's private funding rounds.

Ready to unlock insights on top performing startups?
Ready to unlock insights on top performing startups?